New Delhi: Reflecting on the experience during the last twelve months, representatives from across the clinical research ecosystem in India highlighted the collaborative efforts of stakeholders that contributed to expedited drug development demanded by the pandemic. Experts concurred that this collaboration would be critical as the industry moved ahead, embracing learnings from the pandemic and incorporating advances in digital health. This was the overarching message as over 1200 members of the clinical research fraternity came together to attend the virtual 14th Annual Conference of the Indian Society for Clinical Research (ISCR) based on the theme ‘Clinical Research – Transforming lives: 2021 and beyond.’
“The importance and significance of clinical trials could not have been more amplified than it was in 2020. I am happy to say that as a fraternity, we came together to ensure our commitment to Patients First. It was a period when clinical trials became a household name and we now need to build further trust and confidence amongst members of the public in the safety, efficacy and quality focus of clinical trials,” said Dr Chirag Trivedi, President, ISCR.